MS is considered to be a predominantly T cell-mediated autoimmune disease (118), directed toward various myelin-derived antigens, including myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG), and αB-crystallin (1), that are expressed in the CNS. This evidence concerns the gene MBP and myeloid sarcoma.